Disappointment facing patients with breast cancer as trastuzumab deruxtecan too expensive for NHS. Gourd E. Lancet Oncol 2024 Aug 8:S1470-2045(24)00446.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gourd E. Disappointment facing patients with breast cancer as trastuzumab deruxtecan too expensive for NHS. Lancet Oncol 2024 Aug 8:S1470-2045(24)00446.
PMID: 39128477